Your browser doesn't support javascript.
loading
Antibiotic Treatment is an Independent Poor Risk Factor in NSCLC But Not in Melanoma Patients Who had Received Anti-PD-1/L1 Monotherapy.
Vihinen, Hannes; Jokinen, Artturi; Laajala, Teemu D; Wahid, Nesna; Peltola, Lotta; Kettunen, Tiia; Rönkä, Aino; Tiainen, Leena; Skyttä, Tanja; Kohtamäki, Laura; Tulokas, Sanni; Karhapää, Hanna; Hernberg, Micaela; Silvoniemi, Maria; Mattila, Kalle E.
Afiliação
  • Vihinen H; Department of Oncology and Radiotherapy and Fican West Cancer Centre, University of Turku and Turku University Hospital, POB 52, FIN-20521 Turku, Finland.
  • Jokinen A; Department of Oncology and Radiotherapy and Fican West Cancer Centre, University of Turku and Turku University Hospital, POB 52, FIN-20521 Turku, Finland.
  • Laajala TD; Department of Mathematics and Statistics, University of Turku, Turku, Finland.
  • Wahid N; Department of Oncology and Radiotherapy Vaasa Central Hospital, Vaasa Finland.
  • Peltola L; Department of Oncology and Radiotherapy Vaasa Central Hospital, Vaasa Finland.
  • Kettunen T; Center of Oncology, Kuopio University Hospital, Kuopio, Finland.
  • Rönkä A; Center of Oncology, Kuopio University Hospital, Kuopio, Finland.
  • Tiainen L; Department of Oncology, Tays Cancer Centre, Tampere University Hospital and Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland.
  • Skyttä T; Department of Oncology, Tays Cancer Centre, Tampere University Hospital and Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland.
  • Kohtamäki L; Comprehensive Cancer Center, Helsinki University Hospital and University of Helsinki, Helsinki, Finland.
  • Tulokas S; Comprehensive Cancer Center, Helsinki University Hospital and University of Helsinki, Helsinki, Finland.
  • Karhapää H; Comprehensive Cancer Center, Helsinki University Hospital and University of Helsinki, Helsinki, Finland.
  • Hernberg M; Comprehensive Cancer Center, Helsinki University Hospital and University of Helsinki, Helsinki, Finland.
  • Silvoniemi M; Department of Respiratory Medicine, Turku University Hospital and University of Turku, Turku, Finland.
  • Mattila KE; Department of Oncology and Radiotherapy and Fican West Cancer Centre, University of Turku and Turku University Hospital, POB 52, FIN-20521 Turku, Finland; InFLAMES Research Flagship Center, University of Turku. Electronic address: kalle.mattila@tyks.fi.
Clin Lung Cancer ; 24(4): 295-304, 2023 06.
Article em En | MEDLINE | ID: mdl-36774235
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 6_ODS3_enfermedades_notrasmisibles Base de dados: MEDLINE Assunto principal: Neoplasias Cutâneas / Carcinoma Pulmonar de Células não Pequenas / Neoplasias Pulmonares / Melanoma Tipo de estudo: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Clin Lung Cancer Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 6_ODS3_enfermedades_notrasmisibles Base de dados: MEDLINE Assunto principal: Neoplasias Cutâneas / Carcinoma Pulmonar de Células não Pequenas / Neoplasias Pulmonares / Melanoma Tipo de estudo: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Clin Lung Cancer Ano de publicação: 2023 Tipo de documento: Article